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Abstract  
Background 
Despite increasing evidence of the benefits of early access to palliative care, many patients 
do not receive palliative care in a timely manner. A systematic approach in primary care can 
facilitate earlier identification of patients with potential palliative care needs and prompt 
further assessment. 
Aim: 
To identify existing screening tools for identification of patients with advanced progressive 
diseases who are likely to have palliative care needs in primary health care and evaluate 
their accuracy. 
Design: 
Systematic review (PROSPERO registration number CRD42019111568). 
Data sources:  
Cochrane, MEDLINE, Embase and CINAHL were searched from inception to March 2019 
Results: 
From 4,127 unique articles screened, 25 reported the use or development of 10 screening              
tools. Most tools use prediction of death and/or deterioration as a proxy for the              
identification of people with potential palliative care needs. The tools are based on a wide               
range of general and disease-specific indicators. The accuracy of five tools was assessed in              
eight studies; these tools differed significantly in their ability to identify patients with             
potential palliative care needs with sensitivity ranged 3-94%, and specificity ranged 26-99%. 
Conclusion 
The ability of current screening tools to identify patients with advanced progressive diseases             
who are likely to have palliative care needs in primary care is limited. Further research is                
needed to identify standardised screening processes which are based not only on predicting             
mortality and deterioration, but also on anticipating the palliative care needs and predicting             
the rate and course of functional decline. This would prompt comprehensive assessment to             
identify and meet their needs on time. 
Key Words:  
Palliative care, terminal care, mass screening, primary health care, systematic review, 
advance care planning, symptom assessment, terminally ill 
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What is already known about the topic? 
● Earlier initiation of palliative care can improve quality of care for individuals with             
advanced diseases. 
● However, disease trajectories are highly variable, so it is difficult to identify the              
appropriate time to initiate palliative care.  
● A systematic approach may help to identify patients with advanced progressive           
disease and potential palliative care needs who could benefit from holistic           
assessment. 
What this paper adds 
● Most screening tools use prediction of death and/or deterioration as a proxy for the              
identification of people who are likely to have unmet palliative care needs. 
● The performance metrics for these tools were generally poor. 
 
 
Implications for practice, theory or policy 
● More research is needed to identify a standardised and robust screening tool to 
identify patients with advanced progressive diseases and potential palliative care 
needs in primary care. 
● Future studies should validate screening tools against an appropriate reference 
standard such as palliative care interview to evaluate their ability to identify patients 
with potential palliative care needs. 
● Identification of patients with advanced progressive diseases and potential palliative 
care needs process should be supported by comprehensive and holistic assessment 
to identify their unmet palliative care needs and determine the appropriate care 
pathway. 
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Background  
In Europe, 85% of people now die of chronic diseases such as cancer, heart disease, stroke                
and dementia ​1​. Chronic diseases are characterised by slow progression, fluctuations in           
trajectory, long duration and uncertainty in prognoses ​2, 3​. During advanced stages of chronic             
life-limiting illnesses, patients usually suffer high levels of pain and other physical and             
psychological symptoms​4, 5​. At this stage, patients with any progressive disease could benefit             
from palliative care ​6​. 
There is evidence from randomised controlled trials that earlier access to specialist palliative             
care can promote quality of life, reduce hospital length of stay and hospitalisations, and              
even prolong survival​7-13​. However, ​current evidence shows that palliative care is often            
delivered late in the illness trajectory and access to palliative care is inequitable ​14​. In the UK,                
around 90,000 people with advanced progressive conditions who could benefit from           
palliative care are estimated not to be receiving such care every year​15​. 
One of the key barriers to providing palliative care on time is the difficulty in identifying                
patients who could benefit from it ​16, 17​. Once the patient is identified as having potential               
palliative care needs, their needs can be assessed and addressed in a timely manner.              
However, not all patients with advanced progressive diseases have unmet palliative care            
needs. In addition, busy health care professionals cannot provide holistic assessment for all             
of these patients​18​. ​It has been suggested that a systematic method could facilitate earlier              
identification of a subset of patients with advanced progressive diseases who are likely to              
have unmet palliative care needs and hence benefit from palliative care needs assessment​16,             
19​. 
Since most people with chronic diseases live at home in the last phase of their life, primary                 
care teams are in the best position to identify patients with potential palliative care needs               
who could benefit from palliative care needs assessment​20 ​21 ​22​. Two systematic reviews             
have assessed the screening tools that can be used for the identification of patients who are                
likely to have unmet palliative care needs. However, neither of them examined the accuracy              
of the available tools​16, 23​. This systematic review aimed to identify the existing screening              
tools for identification of patients with advanced progressive diseases who are likely to have              
unmet palliative care needs in primary care and synthesize the available evidence regarding             
their accuracy. 
 
Review questions: 
● What screening tools have been used and studied to identify patients with advanced             
progressive diseases and potential palliative care needs in primary care? 
● What are the main characteristics and differences between these screening tools?  
● What is the accuracy of these screening tools? 
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 Methods 
A positivist approach was used to undertake this systematic review and narrative synthesis 
of the evidence. This research design was selected because the evidence incorporated a 
wide range of screening tools and included data from different study designs not suitable for 
a meta-analysis​24​. The details of the systematic review protocol are provided in PROSPERO 
(CRD42019111568). The systematic review was conducted and reported following Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses protocols (PRISMA-P) guidelines 
25​. 
Criteria for considering studies for this review 
Types of studies 
We included articles that were published in peer-reviewed journals. Commentaries,          
abstracts, posters, letters to the editor, case reports, reviews and unpublished studies were             
excluded. 
Types of participants 
This review included studies examining adults (18 years or older). Studies that reported             
mixed populations of children and adults were included if data for adults were reported              
separately. Only studies which included primary care patients or assessed patients in            
primary care settings were included. Studies which were conducted in mixed settings were             
included as long as they included primary care patients. 
Types of intervention 
We included studies that mentioned the use or development of any screening tool to              
identify patients with advanced progressive diseases who are likely to have unmet palliative             
care needs in primary health care. Any type of screening tool (electronic or manual) was               
considered as long as it has been used to identify primary care patients with potential               
palliative care needs. We also included studies evaluating the ability of the current screening              
tools to identify patients who could have unmet palliative care needs. 
Language  
The search was restricted to articles reported in the English language. 
Search strategy and Study selection 
We searched Cochrane Library, MEDLINE, Embase and CINAHL. A search strategy for            
MEDLINE is presented in Supplementary File 1. Databases were searched from inception to             
the end of September 2018. The search was updated in March 2019 to include articles               
published after September 2018. We searched the reference lists of the included studies             
and the relevant review articles to make sure that all relevant articles were captured. The               
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search strategies were created by one reviewer (Y.E) and peer reviewed by a librarian and               
an information specialist, not otherwise associated with the project. The search results were             
imported into a reference management software package (EndNote X7) and duplicated           
references were removed. 
Abstracts of all identified studies were independently screened for inclusion by two            
reviewers. We obtained the full texts of all abstracts that met the inclusion criteria or where                
there was insufficient information in the abstract alone to determine eligibility. Final article             
selection was carried out after reading full papers by two reviewers. Disagreements related             
to screening were resolved through discussion and where necessary a third researcher was             
consulted. 
Data extraction  
The characteristics of the included studies and screening tools were extracted ​prior to             
synthesis. For studies which assessed the accuracy of the screening tools, specificity,            
sensitivity, positive predictive value, and negative predictive value were either extracted           
from the text or calculated from the reported data. Study authors were contacted to resolve               
any uncertainties, whenever possible. Data were extracted by one reviewer and double            
checked for accuracy by a second reviewer. 
Assessing the risk of bias 
Two independent reviewers assessed the methodological quality and risk of bias in the             
studies that examined the accuracy of the screening tools. Disagreements were resolved            
first through discussion and then by involving a third reviewer for arbitration. For             
observational studies, we used the Newcastle-Ottawa Scale to assess the risk of bias ​26​. The              
methodological quality of these studies was rated on a scale from 0 stars to 9 stars. Studies                 
were classified into groups of low (less than six stars), moderate (7-8 stars), or high (9 stars)                 
quality studies. The quality of randomised clinical trials (RCTs) was assessed using the             
Cochrane Collaboration’s tool for assessing the risk of bias ​27​. This tool evaluates seven             
possible sources of bias. For each individual domain, studies were classified into low,             
unclear and high risk of bias. 
Strategy for data synthesis 
A narrative synthesis was used with information provided in the tables and text to describe               
and summarise the main findings and features of the included studies and the identified              
screening tools. 
 
Results 
Selection of studies 
We identified 6,203 records through the database search and other sources (Figure 1). Of              
these, 2,076 duplicates were removed, leaving 4,127 publications for title and abstract            
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screening. Fifty-seven articles remained following review of title and abstract. A further 32             
articles were excluded following full-text review, resulting in a total of 25 articles. Of these,               
only eight evaluated the accuracy of screening tools. No studies were excluded based on              
their quality assessment. 
 
Figure 1: PRISMA flow chart of the study selection 
 
 
Characteristics of the included studies 
The main characteristics of the 25 articles included in the review are outlined in Table 1​20, 21,                 
28-50​. Most studies were published within the last five years (2015–2019). Of those, 17              
studies were carried out in the United Kingdom (7), the Netherlands (6) and Spain (4).               
Twelve studies were observational (prospective observational and cross-sectional), nine         
studies incorporated mixed methods, three studies were RCTs, and one was a service             
evaluation study. The majority of the studies included patients with a variety of both cancer               
and non-cancer conditions. Seventeen studies were conducted exclusively in primary care           
settings and the remaining studies in mixed settings, including primary care.  
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 Table 1. Characteristics of the included articles 
Tool Author, year country Setting Study design Study objectives  
SQ​ § Barnes, 2008 UK Primary care Prospective 
observational 
study 
To identify predictive factors of mortality of he
failure patients in primary care, and to report t
sensitivity and specificity of prognostic informa
from GPs. 
SQ​ § Moroni, 2014 Italy Primary care Prospective 
cohort  study  
To determine the prognostic accuracy of GPs 
asking the SQ about their patients with advanc
cancer. 
SQ​ § Lakin, 2016 USA Primary care Retrospective 
observational 
study 
To assess the SQ performance in primary care 
setting. 
GSF PIG​ § Clifford, 2016 UK Primary care Service 
evaluation  
To describe the most recent developments and
outline the potential of the updated version of
Gold Programme. 
GSF PIG 
(Italian 
version)​ § 
Scaccabarozzi, 
2018 
Italy Primary care and home 
palliative care units 
Prospective 
observational 
study 
To demonstrate the characteristics of patients
palliative care needs, who early identified by G
and to explore their care process in home palli
care services. 
SPICT 
(German 
version) ​ § 
Afshar, 2018  Germany Primary care Mixed methods To develop, refine, and evaluate SPICT (Germa
version) for its application in primary care. 
SPICT 
(Japanese 
version)​ § 
Hamano, 
2019 
Japan Primary care  Cross-sectional 
study 
To identify the prevalence and characteristics o
primary care patients being at risk of deteriora
and dying, as determined by SPICT. 
SPICT 
(Japanese 
version)​ § 
Hamano, 
2018  
Japan Primary care  Cross-sectional 
study 
To explore the prevalence and characteristics o
family practice patients who need palliative ca
approach as determined using Supportive and
palliative care Indicators Tool. 
SPICT ​ § Highet, 2013 UK Primary care and 
hospital 
Mixed methods To refine and test SPICT tool to help 
multidisciplinary teams, to identify patients at 
of deteriorating and dying in all care settings. 
SPICT 
(Spanish 
version)​ § 
Fachado, 
2018 
Spain Primary care and 
socio-sanitary services  
 Mixed methods To translate, cross-culturally adapt to Spanish,
evaluate the Spanish version of the SPICT. 
SPICT (2012 
version) & 
SQ ​ § 
Mitchell, 2018 Australia Primary care RCT  To test whether screening for likely death with
12 months using SPICT and SQ Is more effectiv
than an intuition approach. 
NECPAL & 
SQ​ § 
Gómez-Batist
e, 2017 
Spain Primary care, hospitals, 
social health centres 
and nursing homes 
Prospective 
cohort study 
To investigate the predictive validity of the NE
and SQ to determine 12- and 24-month morta
NECPAL​ § Gómez-Batist
e, 2014 
Spain Primary care, hospitals, 
social health centres 
and nursing homes 
Cross-sectional 
study. 
To determine  the prevalence of advanced 
chronically ill patients limited life 
prognosis in need of palliative care using NECP
tool 
NECPAL​ § Gómez-Batist
e, 2013 
Spain Primary care, hospitals, 
social health centres 
and nursing homes 
Mixed methods To develop the NECPAL tool to identify patient
need of palliative care. 
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RADPAC​ § Thoonsen, 
2016 
The 
Netherlands  
Primary care Cross-sectional 
study after RCT 
To examine whether trained GPs identified mo
patients in need of palliative care using RADPA
tool and provided 
multidisciplinary care more than untrained GP
RADPAC​ § Thoonsen, 
2015 
The 
Netherlands  
Primary care RCT To train GPs in identifying patients in need of 
palliative care  and in structuring anticipatory 
palliative care planning and studied its effect o
the quality of life. 
RADPAC​ § Thoonsen, 
2012 
The 
Netherlands  
Primary care Mixed methods To develop a tool for identification of patients 
congestive heart failure, COPD and cancer who
could benefit from proactive palliative care in 
primary care. 
PALLI ​ § Vrijmoeth, 
2018​b
 
The 
Netherlands  
Primary care, central 
residential settings and 
intellectual disability 
physician clinics. 
Mixed methods To evaluate feasibility, construct validity and 
predictive validity of PALLI. 
PALLI ​ § Vrijmoeth, 
2018​a
 
The 
Netherlands  
Primary care, central 
residential settings and 
intellectual disability 
physician clinics. 
Mixed methods To describe development of PALLI and to explo
its applicability. 
The double 
SQ​ § 
Weijers, 2018 The 
Netherlands  
Primary care Pilot RCT with 
caged vignettes 
To pilot test whether adding SQ2 to SQ1 prom
GPs to plan for anticipatory palliative care. 
Raincine 
tool​ ⌘  
Raincine, 
2007 
USA Primary care Prospective 
observational 
study 
To develop a methodology to identify patients
may benefit from palliative care and provide 
estimates of their prevalence in primary care. 
AnticiPal 
(updated 
version)​ ​⌘  
Mason, 2018 UK Primary care Mixed methods To refine and evaluate the utility of an electron
ST to help primary care teams screen their pat
for people who could benefit from palliative ca
AnticiPal ​ ​⌘  Mason, 2015 UK Primary care Mixed methods To develop and test an electronic ST in primary
care as a tool to improve patient identification
a palliative care approach. 
  eFI​ ​⌘  Stow, 2018​b UK Primary care  Longitudinal 
population-base
d study (case 
control study) 
To identify frailty trajectories that could indica
increased risk of dying and the need to conside
palliative care. 
  eFI​ ​⌘  Stow, 2018​a UK Primary care  Prospective 
case control 
study 
To examine if changes in eFI could indicate wh
individuals are at increased risk of mortality an
may require palliative care. 
COPD = ​chronic obstructive pulmonary disease; GSF PIG = Gold Standard Framework Proactive Identification Guidance​; ​SPICT= ​the Supporti                 
[Palliative Needs]; ​SQ= ​Surprise Question ​; ​eFI= ​Electronic Frailty Index​; GPs= ​general practitioner; ​PALLI= ​PALliative care: Learning to Ident                  
care; ​ ​ST= ​screening tool;  ​RCT​=​ ​randomised control trial. 
⌘​ = Electronic tools; § ​ = ​Paper-based screening tools. 
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Characteristics of the screening tools 
Ten screening tools, used to identify patients with advanced progressive diseases who are             
likely to have unmet palliative care needs, were identified in this systematic review. Of              
these, nine were originally designed to identify patients with potential palliative care needs             
and one was originally developed to identify patients with frailty (Table 2). Four tools were               
originally developed in the UK (Gold Standard Framework - Proactive Identification           
Guidance: GSF PIG, Supportive, and Palliative Care Indicators Tool: SPICT, AnticiPal           
electronic tool, and Electronic Frailty Index: eFI), three in the Netherlands (RADboud            
indicators for PAlliative Care Needs: RADPAC, PALliative care: Learning to Identify in people             
with intellectual disabilities: PALLI, and the double Surprise Question), two in the United             
States (Surprise Question; SQ, and early identification tool for palliative care patients            
“Rainoe tool”), and one tool in Spain (Necesidades Paliativas [Palliative Needs]: NECPAL            
tool). Seven of the identified tools were paper-based screening tools and three of them              
were electronic case finding tools. The screening object for most of the identified tools was               
to identify patients who are at high risk of deteriorating and dying and might benefit from                
palliative care. The time frame within which symptoms and clinical indicators are assessed             
varies across the screening tools. The PALLI tool assesses the health status over the last 3–6                
months, but the time period for assessment is unspecified for the majority of the symptoms               
and clinical indicators in all other screening tools. Reviewing care, assessment of needs and              
initiating discussions about end-of-life needs are some examples of the recommended           
actions following the screening (Table 3). 
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 Table 2. Summary of the main features of tools which were designed to identify patients with potential palliati
            Tool​a Screening objectives  languages Target 
population  
Setting 
(Primary 
care/GP, 
Hospital) 
Type: 
paper-based 
/electronic 
tool 
Completion time Time frame 
of 
assessment  
cut
SPICT To identify people who 
are at risk of deteriorating 
and dying and might 
benefit from palliative 
care. 
English. 
Japanese, 
German, 
Spanish  
All Primary 
care/GP, 
hospital 
Paper-based SPICT™: few 
minutes 
SPICT-DE:  an 
average of 7.5 
minutes. 
SPICT-ES™: an 
average of 4 
minutes and 45 
seconds. 
Unspecified 
for most 
variables. 
SPIC
and
SPIC
indi
SPIC
indi
indi
NECPAL To Identify people who 
are at high risk of dying 
(who likely in need of 
palliative care). 
Spanish All Primary 
care/GP, 
hospital 
Paper-based NM (one page) Unspecified 
for most 
variables. 
NEC
indi
RADPAC To identify people who 
could benefit from 
palliative care based on 
their clinical indicators. 
Dutch COPD, 
congestive 
heart failure 
and  cancer 
patients 
Primary 
care/GP 
Paper-based NM (one page) Unspecified 
for most 
variables. 
No 
GSF PIG To identify people who 
may be in their final stage 
of life who could benefit 
from an early palliative 
approach. 
English, 
Italian 
All Primary 
care/GP, 
hospital 
Paper-based NM (one page) Unspecified 
for most 
variables. 
GSF
indi
PALLI To identify patients with 
intellectual disability who 
may benefit from 
palliative care via 
screening deteriorating 
health, indicative of a 
limited life expectancy. 
Dutch Patients 
with 
intellectual 
disabilities 
Primary 
care/GP 
Paper-based Mean time  of 10.5 
minutes 
(physicians) and 
10.1 minutes (daily 
care professionals) 
Previous 3-6 
months for all 
domains 
except 
fragility. 
No 
Surprise 
Question  
To identify patients with 
poor prognosis who 
might benefit from 
palliative care. 
English, 
Italian 
All Primary 
care/GP, 
hospital 
Paper-based NM (one question) NA SQ +
que
The 
double SQ 
To identify patients with 
poor prognosis who 
might benefit from 
palliative care. 
Dutch, 
Slovak 
All Primary 
care/GP, 
hospital 
Paper-based NM ( two 
questions) 
NA The
of S
AnticiPal To identify patients who 
potentially have 
deteriorating health due 
to one or more advanced 
illnesses and a likelihood 
of unmet supportive and 
palliative care needs. 
English All Primary 
care/GP 
Electronic NA Unspecified 
for most 
variables. 
Previous 18 
months for 
Codes that 
indicate 
malignancy. 
Ant
incl
the 
The
Typ
pan
Typ
at 
Com
Diff
dem
Racine tool To identify people who 
are at high risk of death 
(who may benefit from 
palliative care. 
English All Primary 
care/GP 
Electronic  NA NA Pati
elec
leas
risk
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e.g.
con
COPD = ​chronic obstructive pulmonary disease;​ GSF PIG​ =​ Gold Standard Framework Proactive Identification Guidance​; SPICT​=​ the​ Supportive & palliat
Paliativas [Palliative Needs];​ ​SQ= ​Surprise Question​; GPs= ​general ​practitioner; ​PALLI=​ ​palliative care: Learning to Identify in people with intellectual dis
positive.  
a ​ ​The most recent version of the tool  
 
 
Table 3. Summary of the general and specific indicators of deteriorating health and increasing needs in t
with potential palliative care needs. 
 GSF PIG SPICT  NECPAL  RADP
      Surprise Question (SQ) Yes  No (SQ was part of some previous 
versions of SPICT but was 
removed from the recent 
versions of SPICT in different 
languages) 
Yes  No 
      Nutritional decline Progressive weight loss 
(>10%) in the past six months  
Serum albumen <25g/l 
Progressive weight loss or 
remains underweight 
Low muscle mass 
Weight loss > 10% 
NM 
      Functional decline  
 
In bed or chair 50% of the day 
 
 
General physical  and 
performance status decline ( 
Barthel score) and decreasing 
activities 
 
Increasing dependence  and 
need for support 
In bed  or chair >50% of the day 
 
 
Poor or deteriorating 
performance status 
 
 
Dependent and increasing need 
for support 
- 
 
 
Karnofsky or Barthel score > 
30%  
loss of two or more activities of 
the daily living  
 
Severe Dependence (Karnofsky 
<20) 
NM 
      Cognitive decline  - NM Minimental/Pfeiffer Decline 
NM 
      Symptom burden Unstable, deteriorating, 
complex symptom burden 
Persistent symptoms despite 
optimal treatment 
Persistent symptoms (e.g. Pain, 
weakness, anorexia, dyspnoea, 
digestive) 
NM 
      Psychosocial decline 
NM NM Present of emotional stress (Detection of Emotional 
Distress Scale (DME) > 9) 
Severe Social Vulnerability 
(Social and family assessment) 
NM 
      Multi-morbidity Significant multi-morbidities. NM >2 chronic diseases 
NM 
      Urgent/unplanned 
admissions 
Repeated unplanned hospital 
admissions  
Unplanned hospital admission(s). • > 2 urgent or not planned 
admittances in last 6 months NM 
      Presence of an adverse 
event 
Sentinel event e.g. serious 
fall, bereavement, transfer to 
nursing home  
NM Geriatric syndromes ​(​at least 
two):  
Falls, pressure ulcers, 
dysphagia, delirium, recurrent 
infections. 
NM 
Others  Considered eligible for DS 
1500 payment​a 
   
      Choice of no further 
active treatment/ no 
Choice for no further active 
treatment 
Chooses to reduce, stop or not 
have treatment (patient or 
family) 
Limitations of therapeutic 
effort were mentioned by 
patient, family or the team 
NM 
12 
 
curative treatment 
available  
Choosing or requiring 
palliative care 
Asks for palliative care by 
patient 
Asks for palliative care  by patient 
or family 
Asks for palliative care by 
patient, family or the team NM 
Additional specific clinical 
indicators for 
Cancer, heart disease, COPD, 
kidney disease, liver disease, 
general neurological diseases, 
Parkinson’s disease, motor 
neurone disease, multiple 
sclerosis, frailty, dementia, 
stroke. 
Cancer, heart/ vascular disease, 
kidney disease, liver disease, 
neurological disease, respiratory 
disease, dementia/ frailty. 
Cancer, COPD, chronic heart 
disease, chronic neurological 
disease (CVA, ALS, motor 
neurone disease, multiple 
sclerosis), dementia. 
COPD
failure
COPD = ​chronic obstructive pulmonary disease ​ GSF PIG​ =​ Gold Standard Framework Proactive Identification Guidance​; SPICT​=​ the​ Supportive &
[Palliative Needs];​ ​SQ= ​Surprise Question​; PALLI=​ ​PALliative care: Learning to Identify in people with intellectual disabilities​; NM​= ​not mentione
a​ DS 1500   is a Form for patients who are terminally ill who are not expected to live for more than six months to rapidly access benefits in the U
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Table 3 summarises the general and specific indicators of the screening tools for             
identification of people with potential palliative care needs in primary care. The Surprise             
Question is part of all of the paper-based tools (except the RADPAC and the current versions                
of SPICT). Five tools (GSF PIG, SPICT, NECPAL, PALLI and AnticiPal) contain general indicators              
for decline and increasing needs such as repeated unplanned hospital admissions,           
progressive weight loss and functional decline. Only NECPAL and PALLI contain indicators for             
psychological and cognitive decline. Six tools (GSF PIG, SPICT, NECPAL, RADPAC, PALLI and             
AnticiPal) contain additional disease-specific clinical indicators of decline for a number of            
medical conditions. In the paper-based tools, the number of items or questions varied             
significantly and ranged from 1 to 42. The remainder of this section describes the included               
tools which used to identify patients who may benefit from palliative care in primary care. 
 
1. The Surprise Question (SQ), which was originally developed by Lynn, is the first tool 
that has been used for this purpose​37, 56​. It is utilised as a part of some screening tools 
or used in isolation. The SQ asks whether the respondent would be surprised if the 
patient died within a specified time period (usually the next year). The SQ has been 
widely validated in different settings​35, 37, 45​. The proportion of patients identified by 
SQ as having potential palliative care needs across studies ranged from 1.6 to 79%. In 
those studies applied to patients with advanced progressive diseases, the percentage 
of patients identified by SQ as having potential palliative care needs ranged from 
41% to 79% whereas that applied SQ to more general populations reported 
percentages between 1.6% and 11.7% ​35, 37, 45​. 
 
2. The double Surprise Question was developed by adding an additional question (SQ2)            
that asks whether the respondent would be surprised if the patient is still alive after               
12 months?” when SQ1 is answered in the negative​50​. The purpose of adding the              
second SQ was to increase the predictive value of SQ1. The validity of this tool has                
not been explored yet, although a pilot study concluded that the majority of GPs              
considered it a useful addition to SQ1​50​. 
 
3. The GSF PIG was developed in the UK ​28, 29​. The tool, which is applicable across care                 
settings, uses the Surprise Question, along with general and disease-specific          
indicators of decline and increasing need. To the authors' knowledge, there is no             
underlying research about the development of GSF PIG, and no validation studies            
have been performed in primary care settings in the UK. The GSF PIG has been               
translated and adapted for the Italian context​28​. An Italian study which utilised the             
GSF PIG among primary care patients found that 0.67% of the patients identified as              
having a low life expectancy, and palliative care needs ​28​.  
 
4. The SPICT was developed in the UK using a process of literature review, peer review               
and a prospective case-finding study​33​. It is a one-page tool which consists of a              
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combination of general indicators of deteriorating health and disease-specific         
indicators. The SPICT had been translated and adapted to Japanese, German, and            
Spanish settings ​20, 30, 32​. These translated versions (in addition to the original English              
version) have been validated in a wide range of inpatient and outpatient clinical             
settings​20, 30, 32, 33, 37​. Various cut-off scores were used in different versions of SPICT               
(Table 3). Studies in Australia and Japan that used SPICT among old patients in              
primary care showed that between 5.1% and 17.3% of these patients could benefit             
from palliative care​37​ ​20, 31​. 
 
5. Mason et al. developed an electronic tool called AnticiPal based on the SPICT criteria              
43​. This electronic tool was developed initially through an iterative process of            
designing, implementation and testing. In a recent study to evaluate the utility of             
AnticiPal in Scotland, around 0.8% of 62,708 registered patients at eight GP practices             
were identified as having potential palliative care needs​44​. 
 
6. The NECPAL tool was developed in Catalonia, Spain based on SPICT and the GSF PIG               
tools ​36​. This instrument, the NECPAL, is a checklist which combines the SQ with              
general clinical indicators of severity and progression (e.g. co-morbidity and resource           
use); and specific indicators for some medical conditions. NECPAL has been validated            
in a wide variety of care settings​15, 34-36​. Recent Spanish observational studies which             
conducted in multiple setting including primary care settings found ​that 1.5% of            
primary care patients and 73.7% of patients with advanced progressive diseases met            
the NECPAL criteria and could benefit from palliative care ​34, 35​. 
 
7. The RADPAC tool was developed in the Netherlands through a three-step process            
comprising a literature search, focus group interviews and a Delphi study with GPs ​38​.              
The RADPAC tool contains specific indicators for congestive heart failure, chronic           
obstructive pulmonary disease (COPD), and cancer; although it does not include the            
Surprise Question or general clinical indicators which can be applied to all patients. A              
Dutch RCT on the effects of training GPs in early identification of patients who could               
benefit from palliative care using the RADPAC tool did not find any differences             
between the intervention and control group in out-of-hours contacts, contacts with           
their GP, hospitalisations and place of death​40​. The study also revealed that only one              
in four patients who died had been identified as in need of palliative care. 
 
8. The PALLI tool was designed to be used to identify people with intellectual             
disabilities who may benefit from palliative care​41​. The tool was developed in the             
Netherlands using five-stage mixed methods design including retrospective survey,         
interviews, draft version, focus groups and finalisation for testing in practice. This            
tool, which consists of 39 questions, composed of eight main themes such as             
physical decline, changes in characteristic behaviour, and increases in symptom          
burden. The PALLI tool has been validated for use among patients with intellectual             
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disabilities in different settings, including primary care ​50​. PALLI tool shows promising           
construct validity and feasibility. There is, however, less and mixed evidence for the             
predictive validity of this tool​50​. 
 
9. Rainoe et al. used computerized electronic records to identify the most common            
factors associated with death within the next year among hospitalised patients ​21​. A            
list of the identified factors (including age 75 and over and having diseases, such as               
heart failure and COPD) was used to identify people who may benefit from palliative              
care. The electronic tool has been validated against clinical assessment in an            
observational study in the USA, which found that 5.6% of primary care patients could              
benefit from palliative care​21​. 
 
10. Electronic Frailty Index (eFI) was developed in the UK to identify elderly patients in              
primary care who may be living with frailty ​48​. The eFI uses a ‘cumulative deficit’              
model to calculate a frailty score based on a range of deficits, which can be               
symptoms, signs, diseases and abnormal laboratory test values. The eFI has been            
used in two recent studies to identify people who are at increased risk of mortality               
and may need palliative care​48, 49​. Initially, Stow et al. examined the ability of eFI to                
predict mortality by measuring it at a single time point, which found that 1.1% of               
individuals age 75 and over could benefit from palliative care​48​.  
Stow et al. conducted another study using eFI to examine if changes in frailty index               
can be used to predict mortality and the need to palliative care ​49​. The study              
identified a distinct frailty trajectory which can be used to identify people who are at               
a higher risk of dying within 12 months. This study found that 0.49% of people age 75                 
and over were identified as potential candidates for palliative care. The predictive            
validity of eFI to identify patients with potential palliative care needs has been             
evaluated in both studies​48, 49​. 
 
Accuracy of screening tools 
Eight studies reported accuracy data for five screening instruments (SPICT, SQ, NECPAL, eFI             
and early identification tool for palliative care patients “Rainoe tool”)​21, 35, 37, 45-49​. Reference              
standards (i.e. the comparator against which the tool was compared) varied across these             
studies, including 3-month mortality, 12-month mortality, 24-month mortality and clinical          
assessment. One study was excluded as data were available only on positively screened             
patients​28​. Table 4 shows a summary of the sensitivity, specificity, positive predictive value,             
and negative predictive value for the screening tools. 
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 Table 4: ​ ​Summary of the sensitivity, specificity, positive predictive value, negative predictive value for the scree
Reference Length of 
Follow-Up 
Comparison Tool  Cut-off ​ ​value Reference standard  Final 
sample(n)  
 
Age, m
medi
range
Mitchell, 
2018 
12 months  
 
Intuition 
 
SPICT 
(2012 
version) 
 SQ+ with ≥2  general indicators or ≥1 clinical 
indicator ) 
h Mortality  1525 
 
79.1, 
SQ  swer no to the ‘surprise’ question) h Mortality 
Gómez-Bat
iste 2017 
24 months No NECPAL  
NECPAL+ (SQ+, and  “≥1 general indicators 
or ≥1 specific indicators”) 
12-months mortality  
1059 
 
81.3, 
11.8) 
24-months mortality 
SQ 
SQ + (answer no to the ‘surprise’ question) 12-months mortality 
24-months mortality 
Raincine, 
2007 
6-month 
(the length 
of the 
study) 
No 
 
Raincine 
tool 
Patient is included if their electronic 
records contained at least one of the 
marker for high risk of death within the 
next year e.g. age >75 or a diagnosis of 
congestive heart failure. 
Clinical assessment  
 18308 
- 
Barnes, 
2008 
12 months No SQ SQ + (answer no to the ‘surprise’ question) 12-months mortality 231  77,  m
71-82
Moroni, 
2014 
 
12-months No SQ swer no to the ‘surprise’ question) hs mortality 231 70.2  
Lakin, 
2016 
12-months No SQ swer no to the ‘surprise’ question) hs mortality 1737 65, m
Stow, 
2018​b 
12 months  No eFI with rapidly rising frailty ( initial increase of 
0.022 eFI per month before slowing from a 
baseline eFI of 0.21) 
hs mortality 26,298 For ca
mean
For co
mean
Stow, 
2018​a
3 months No eFI alue > 0.19 s mortality 7890 For ca
mean
For co
mean
SPICT=​ ​the Supportive & Palliative Care Indicators Tool; ​NECPAL= ​Necesidades Paliativas [Palliative Needs];​ ​SQ= ​Surprise Question​; eFI = ​electronic Frailty 
predictive value; ​NPV=​ negative predictive value; ​+ =​ positive. 
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Across all screening tools and studies, only one study had a positive predictive value over               
50% (83.8%). The negative predictive value was high for most tools and varied from 99% to                
69%. The sensitivity and specificity values varied considerably and ranged from 3.2% to 94%              
and 26.4% to 99% respectively. Studies enrolling participants with advanced progressive           
diseases reported high sensitivity values; however, studies that targeted a general           
population of primary care (e.g. adults aged 70 and over) reported lower sensitivity values. 
 
Methodological quality of studies which reported accuracy data for screening 
tools 
The assessment of the risk of bias is summarized in Supplementary File S2. (RCTs),              
Supplementary File S3a. (cohort studies) and Supplementary File S3b. (case control studies).            
On the basis of the Newcastle–Ottawa scale, three of the five cohort studies were judged to                
bear a moderate risk of bias (fair quality)​35, 46, 47 and one cohort was judged to have a high                   
risk of bias (low quality) due to the lack of description of the follow-up and no adjustment                 
for confounders ​21​. Only one cohort study fulfilled most of the Newcastle-Ottawa scale            
criteria and had a low risk of bias (high quality) ​45​. Newcastle–Ottawa scale assessment              
revealed that the two case control study were all of a fair quality ​48, 49​. Based on the Cochrane                  
risk of bias tool, the overall risk of bias for the included RCT was high because of unclear                  
allocation concealment and differential drop-out rates ​between the two groups​37​. 
 
Discussion 
Main findings 
We identified 10 screening tools for identification of patients with advanced progressive            
diseases who are likely to have unmet palliative care needs in primary care which varied in                
content and accuracy, and in general, the validation studies were of low quality and with               
high risk of bias. 
Most of the identified tools use either prediction of death or deterioration or both as               
proxies for the identification of people who are likely to have unmet palliative care needs.               
Patients with advanced progressive diseases experience different trajectories of decline and           
usually have varying needs at different phases in the illness trajectory​51, 52​. Therefore, the           
identification process should not be based solely on predicting mortality or survival, but it              
should also focus on anticipating their needs whenever they occur, and predicting the rate              
and course of functional decline in order to trigger holistic assessment and make a proactive               
palliative care plan.  
The proportion of patients identified with potential palliative care needs across studies            
ranged from 0.49% to 79%. The accuracy of five tools (of which data were available in 8                 
studies) showed sensitivity ranging from 3.2% to 94%, and specificity ranging from 26.4% to              
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99%. The wide variation in the accuracy of the screening tools may be caused by both                
variations in diagnostic groups and disease trajectory during the last year of life.  
 
 
Strengths and weaknesses/limitations of the study  
This is the first systematic review to assess the evidence on accuracy of screening tools for                
identification of patients ​with advanced progressive diseases who are likely to have unmet             
palliative care needs in primary care. We used a broad search strategy to identify all               
potentially relevant studies b​y searching Cochrane Library, MEDLINE, Embase and CINAHL,           
and we evaluated ​the quality of the validation studies using two reviewers independently             
with disagreements resolved​ ​by a third reviewer. 
Our findings are limited by several issues. Firstly, our search strategy was designed to              
capture all of the relevant papers but given the nature of this topic, it is possible that some                  
papers may have been missed. Although we conducted a comprehensive and broad search            
of the literature, we only included English language studies. We did not also include              
unpublished results or studies from the grey literature which may have introduced            
publication bias. However, the methodological quality of grey literature is usually lower than             
the quality of published studies literature ​53, 54​. Secondly, there is no current consensus about              
a reference standard against which the accuracy of a screening tool could be assessed. All               
studies used mortality as a reference standard, with the exception of one study that used               
clinical judgment to determine whether the identified patient could benefit from palliative            
care​21​. This is a major flaw in the evidence, in that we know palliative care needs do not                  
relate particularly closely to time to death, especially for some illnesses such as organ              
failures. Data were universally missing on how many patients identified (or missed) by the              
screening tools actually had palliative care needs and so we cannot be certain of the true                
clinical value of these tools.  
What this study adds 
Improving identification of patients who are likely to have unmet palliative care needs is a               
crucial step to overcome inequity in access to palliative care and to ensure that patients               
receive the right care at the right time to meet their needs and preferences​55 ​16​.               
Identification does not mean referral to specialist palliative care services is necessarily            
needed, but rather, it should trigger comprehensive and holistic assessment of palliative            
care needs of the identified patients and their families ​17, 56​.  
 
Although some of the identified tools recommended some actions to be taken after the              
screening process, there is no clear or appropriate care pathway for people with advanced              
progressive diseases who have been identified as having potential palliative care needs.            
Based on the findings from this review, we created a conceptual graph to describe the               
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process of patient identification and assessment of palliative care needs (Figure 2). The first              
step in the process is using a screening tool to aid the identification of patients with                
advanced progressive diseases whose health is deteriorating and hence benefit from           
palliative care needs assessment. The screening tool should be based not solely on             
predicting mortality and deterioration but also on anticipating the needs whenever they            
occur and predicting the rate and course of functional decline. The identified patients who              
have potential palliative care needs could then be targeted for assessment to identify their              
unmet palliative care needs. The outcomes of the assessment can help to determine the              
level of care required and may prompt an introduction of a palliative care approach              
‘generalist palliative care’ or referral to a specialist palliative care service. 
Figure 2: The process of patient identification and assessment of palliative care needs 
 
 
Primary care teams play a vital role in caring for people with advanced chronic diseases​57​.               
One of the main challenges for them is to identify which of their patients might have unmet                 
palliative care needs​58, 59​. Implementing a systematic tool could help the primary care team              
to identify patients with advanced progressive diseases and potential palliative care needs.            
However, issues such as high workload and decreased resources and capacity in primary             
care can be barriers to implement such a screening tool​43​. Therefore, we recommend the              
use of an electronic tool to systematically and automatically identify patients who might             
have unmet palliative care needs and trigger the use of a needs assessment tool. Although               
there are some electronic screening tools which have been used such as AnticiPal ​and              
Rainoe tools, their validity is unclear as they used the risk of deteriorating and dying as a                 
proxy for the identification of people with potential palliative care needs ​21, 44, 57​.  
The design of the future automated tools should be based on predicting functional decline              
and increasing needs as well as predicting mortality. Future studies of these tools should              
apply adequate reference standards such as palliative care interviews to examine whether            
the screening tools accurately identifies patients with potential palliative care needs ​56, 60​.             
The implementation and use of these tools within current clinical practice software required             
minimal resources and very little training and capacity which allow them to be used in busy                
primary care practices​18, 61​. Implementation of validated ​and standardized screening tools           
would transform the identification process ​in primary care and improve timely access to             
palliative care for people with advanced progressive diseases and potential palliative care            
needs.  
Conclusion 
This systematic review identified 25 studies that reported the use or development of             
screening tools to identify patients who are likely to have unmet palliative care needs. The               
evaluation of these tools was limited because of a lack of a valid comparator and so their                 
true clinical utility is unknown. Further research is needed to identify standardised screening             
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processes which are based not solely on predicting mortality and deterioration but also on              
anticipating a person’s needs whenever they occur and predicting the rate and course of              
functional decline in order to ​trigger the use of a needs assessment tool to identify and                
address their unmet needs at the right time. 
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Supplemental material for [Identification of patients with potential palliative care needs: a 
systematic review of screening tools in primary care] 
 
Index  
S1: The search strategy used on MEDLINE. 
S2: Bias assessment for randomized control trials (Cochrane risk of bias tool) 
S3a: Bias assessment for cohort studies (Newcastle–Ottawa Scale) 
S3b: Bias assessment for case control studies (Newcastle–Ottawa Scale) 
S4: PRISMA checklist. 
 
Supplementary file 1. the search strategy used on MEDLINE. 
1. (Family adj3 Physician* or doctor* or Practi* or medicine).ti,ab. 
2. (general adj3 pract*).ti,ab. 
3. (GP or GPs).ab,ti. 
4. (primary adj3 care).ab,ti. 
5. Primary Health Care/ 
6. Family Practice/ 
7. Physicians, Family/ 
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
9. "Referral and Consultation"/ 
10. Mass Screening/ 
11. tool*.ab,ti. 
12. Risk Assessment/ 
13. instrument*.ab,ti. 
14. diag*.ab,ti. 
15. consultation.ab,ti. 
16. identif*.ab,ti. 
17. (case adj3 finding).ab,ti. 
18. screen*.ab,ti. 
19. assessment.ab,ti. 
20. detection.ab,ti. 
21. 9 or 10or 11 or 1214 or 15 or 16 or 17 or 18 or 19 or 20 
22. Palliative Care/ 
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23. PALLIATIVE MEDICINE/ 
24. Advance Care Planning/ 
25. TERMINAL CARE/ 
26. Terminally Ill/ 
27. Palliat*.ab,ti. 
28. (terminal adj3 Care).ab,ti. 
29. (advance adj3 care adj3 plan*).ab,ti. 
30. (end adj3 life adj3 care).ab,ti. 
31. (end-of-life adj3 care).ab,ti. 
32.  (terminal* adj3 ill* or patient* disease*).ab,ti. 
33. ((near or approach* or close) adj4 (death ordying)).ab,ti. 
34. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 
35. 8 and 21 and 34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary file 2. ​Bias assessment for randomized control trials (Cochrane risk of bias tool) 
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Reference Random sequence 
generation (selection 
bias) 
Allocation 
concealment 
(selection bias) 
Blinding of 
participants 
and researchers 
 
Blinding of outcome 
assessment 
(detection bias) 
Incomplete 
outcome data 
(attrition bias) 
Selective 
reporting 
(reporting bias) 
Other 
bias 
Mitchell, 2018 Low Unclear​a Low Low High​b Low Low 
a​ Unclear allocation concealment. 
b​ Differential drop-out rates between the two groups. 
 
 
Supplementary file 3.a.Bias assessment for cohort studies  (Newcastle–Ottawa Scale) 
Domain Selection Comparability Outcome 
Reference Representativene
ss of cohort 
Selection 
of 
non-expos
ed cohort 
Ascertainmen
t of exposure  
Outcome 
of interest 
Comparability 
of cohorts 
Assessment 
of outcome 
Adequate 
duration 
of 
follow-up 
Adequate 
follow-up 
of cohort 
Total 
score 
Gómez-Ba
tiste 2017,  
1 1 0 1 2 1 1 1 8 
 
Rainone, 
2007, 
1 1 1 1 0 1 1 0 6 
 
Barnes, 
2008, 
1 1 1 1 0 1 1 1 7 
 
Moroni, 
2014, 
 
1 1 1 1 1 1 1 1 9 
 
Lakin, 
2016 
1 1 1 1 1 1 1 1 7 
 
Supplementary file 3b. Bias assessment for case control studies  (Newcastle–Ottawa Scale) 
Domain Selection Comparability Comparability Total 
score 
Author, 
year 
Is the case definition 
adequate? 
Represe
ntativen
ess of 
the 
cases 
Selection of 
Controls 
Definition 
of 
Controls 
Comparability 
of cohorts 
Ascertainme
nt of 
exposure 
Same 
method of 
ascertain
ment for 
cases and 
controls 
Non-Resp
onse rate 
 
Stow, 
2018​b 
1 1 1 1 1 1 1 1 8  
Stow, 
2018​q 
1 1 1 1 1 1 1 1 8 
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